6 November 2024 - Health Minister Mark Butler has directed the PBAC to hold an unprecedented extra meeting, after the government’s independent drug assessor deferred consideration of 45 new medicines.

The additional May 2025 meeting will judge the full range of deferred submissions, which would have seen at least 120 days of additional delays under the previous decision.

Read The Australian article